2006 Hospitals Pharmaceutical Manufacturing 
Drug Channels
MARCH 15, 2022
Licenses for our DCI reports are regularly purchased by nearly every company involved in the drug channel: pharmaceutical manufacturers, wholesalers, pharmacists, pharmacy owners, hospitals, buyers, benefit managers, managed care executives, policy analysts, investors, consultants, and more. d/b/a Drug Channels Institute.
Drug Channels
OCTOBER 11, 2022
contains new data on hospital acquisitions and consolidation activity. examines how the Inflation Reduction Act could ultimately impact pharmaceutical wholesalers’ customers and business outlook. Copyright © 2006-2022 Pembroke Consulting, Inc. Section 6.1.6. In some small way, I try to make the world a better and smarter place.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Channels
OCTOBER 5, 2021
Licenses for our DCI reports are regularly purchased by nearly every company involved in the drug channel: pharmaceutical manufacturers, wholesalers, pharmacists, pharmacy owners, hospitals, buyers, benefit managers, managed care executives, policy analysts, investors, lawyers, consultants, and more.
Drug Channels
MARCH 14, 2022
You'll meet an impressive diversity of people from pharmacies, manufacturers, health plans, wholesalers, hospital systems, pharmacy benefit managers, patient advocacy groups, and more. Copyright © 2006-2022 Pembroke Consulting, Inc. This is a must-attend event for anyone connected to specialty pharmacy.
pharmaphorum
MARCH 8, 2022
Four years ago, I pivoted in my career, becoming a mechanical design engineer for a Manchester-based Heating, Ventilation and Air Conditioning (HVAC) company – designing air handling units for hospitals, pharmacies, schools and supermarkets. In October 2021, I joined the engineering department at Envair Technology, designing isolators.
PharmaShots
FEBRUARY 27, 2023
facility for manufacturing biologics in his presentation. —a combination of AI, IoT, and Digital Twins—for pharmaceutical manufacturers. Dr. Samir discussed Agilent's new Agilent University idea as well as how the company is creating analytical solutions to enable the smart manufacture of biologics.
Drug Channels
OCTOBER 13, 2020
Licenses for our DCI reports are regularly purchased by nearly every company involved in the drug channel: pharmaceutical manufacturers, wholesalers, pharmacists, pharmacy owners, hospitals, buyers, benefit managers, managed care executives, policy analysts, investors, consultants, and more. d/b/a Drug Channels Institute.
Expert insights. Personalized for you.
98 
Let's personalize your content